Wildcat Capital Management LLC 13D and 13G filings for Silexion Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-26 4:15 pm Purchase | 2025-06-26 | 13D | Silexion Therapeutics Ltd. SLXN | Wildcat Capital Management LLC | 7,562 1.300% | 7,562 (New Position) | Filing |